{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T10:02:26Z","timestamp":1780135346178,"version":"3.54.0"},"reference-count":35,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:00:00Z","timestamp":1780099200000},"content-version":"vor","delay-in-days":149,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Infectious Diseases and Medical Microbiology"],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:p>\n                    In nations with developing healthcare infrastructures, the dual burden of Type 2 diabetes mellitus (T2DM) and tuberculosis represents a critical health challenge. The aim of this study is to investigate the influence of T2DM on the development of multidrug\u2010resistance tuberculosis (MDR\u2010TB) in relation to genetic mutations of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    in Ethiopia. A facility\u2010based cross\u2010sectional study was carried out between 2023 and 2024. Genetic mutations associated with drug resistance in both diabetic and nondiabetic groups were detected using line probe assays (LPAs). Diagnosis of T2DM was performed using fasting blood glucose and glycated hemoglobin levels. Data were analyzed with SPSS software, and logistic regression models were performed. Our findings revealed that 44 of the 182 participants (24.2%) were TB\u2013T2DM, whereas 138 (75.8%) were TB with nondiabetic groups. Multivariate analysis displayed that the prior TB treatment history (aOR: 2.51, 95%CI: 1.02\u20136.19,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.046) and a family history of T2DM (aOR: 2.25, 95% CI: 1.10\u20134.60,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.031) were independently associated with an increased risk of TB\u2013T2DM comorbidity. Genetic analysis identified a total of 50 mutations (22\n                    <jats:italic>rpoB<\/jats:italic>\n                    , 22\n                    <jats:italic>katG<\/jats:italic>\n                    , and 6\n                    <jats:italic>inhA<\/jats:italic>\n                    promoter) associated with resistance to RIF and INH drugs among 31 drug\u2010resistant\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    isolates, which were significantly more common in TB\u2013T2DM comorbid patients (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.009). The\n                    <jats:italic>rpoB<\/jats:italic>\n                    S450L and\n                    <jats:italic>katG<\/jats:italic>\n                    S315T1 were the predominant mutations typically associated with high\u2010level RIF and INH resistance, respectively, and high biological fitness, allowing for successful transmission within the community. Among the dual mutations identified in MDR\u2010TB isolates, only the\n                    <jats:italic>rpoB<\/jats:italic>\n                    UN\u2009+\u2009\n                    <jats:italic>katG<\/jats:italic>\n                    S315T1 mutation was significantly more prevalent in nondiabetics (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.04) compared to the TB\u2013T2DM comorbid group. Multivariate analysis revealed that prior TB treatment history (aOR: 4.00, 95% CI: 1.31\u201312.50,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.014) and TB\u2013T2DM comorbidity (aOR: 3.12, 95% CI: 1.02\u20139.10,\n                    <jats:italic>p<\/jats:italic>\n                    = 0.042) were significantly associated with an increased likelihood of MDR\u2010TB. This increased odd of resistance in comorbid patients highlights the need for bidirectional T2DM screening for all TB patients, particularly those with a history of prior TB treatment or a family history of diabetes. A genome\u2010wide association study into the mutation patterns responsible for DR is crucial to inform the development of targeted, effective strategies moving forward.\n                  <\/jats:p>","DOI":"10.1155\/cjid\/7830270","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:38:01Z","timestamp":1780133881000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Influence of Diabetes Mellitus on the Development of Multidrug\u2010Resistant Tuberculosis (MDR\u2010TB) in Relation With Genetic Mutations of\n                    <i>M. tuberculosis<\/i>\n                    Isolates in Ethiopia"],"prefix":"10.1155","volume":"2026","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1304-7129","authenticated-orcid":false,"given":"Aynias","family":"Seid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0352-2341","authenticated-orcid":false,"given":"Semira","family":"Nureddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,5,30]]},"reference":[{"key":"e_1_2_13_1_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)01301-6"},{"key":"e_1_2_13_2_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1122255"},{"key":"e_1_2_13_3_2","volume-title":"Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycaemia: Report of a WHO\/IDF Consultation","author":"World Health Organization","year":"2006"},{"key":"e_1_2_13_4_2","doi-asserted-by":"publisher","DOI":"10.1093\/OFID\/OFAA106"},{"key":"e_1_2_13_5_2","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2020.5478"},{"key":"e_1_2_13_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcle.2021.04.006"},{"key":"e_1_2_13_7_2","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v15.i5.853"},{"key":"e_1_2_13_8_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1044426"},{"key":"e_1_2_13_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e30939"},{"key":"e_1_2_13_10_2","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1368"},{"key":"e_1_2_13_11_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab1067"},{"key":"e_1_2_13_12_2","volume-title":"Global Tuberculosis Report 2025","author":"WHO","year":"2025"},{"key":"e_1_2_13_13_2","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S248054"},{"key":"e_1_2_13_14_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09111-8"},{"key":"e_1_2_13_15_2","doi-asserted-by":"publisher","DOI":"10.3390\/epidemiologia4020021"},{"key":"e_1_2_13_16_2","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.15543"},{"key":"e_1_2_13_17_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/3524926"},{"key":"e_1_2_13_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-07017-3"},{"key":"e_1_2_13_19_2","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2023.1244450"},{"key":"e_1_2_13_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.therap.2022.05.005"},{"key":"e_1_2_13_21_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.973991"},{"key":"e_1_2_13_22_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S412951"},{"key":"e_1_2_13_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/20503121231208266"},{"key":"e_1_2_13_24_2","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/1967675"},{"key":"e_1_2_13_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms12020324"},{"key":"e_1_2_13_26_2","article-title":"Genexpert\u00ae Operator\u2019s Manual and the Xpert\u00ae MTB\/RIF Protocols (CD-ROM) for Compre_Hensive Operating Instructions, Including Important Warnings Relating to Operator Safety","volume":"39","author":"Cepheid","year":"2013","journal-title":"Animal Genetics"},{"key":"e_1_2_13_27_2","first-page":"775","article-title":"Sputum Digestion and Decontamination With N-Acetyl-Lcysteine-Sodium Hydroxide for Culture of Mycobacteria","volume":"87","author":"Kubica G. P.","year":"1963","journal-title":"American Review of Respiratory Disease"},{"key":"e_1_2_13_28_2","first-page":"47","volume-title":"Mycobacteriology Laboratory Manual","author":"GLI","year":"2014"},{"key":"e_1_2_13_29_2","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.000726"},{"key":"e_1_2_13_30_2","volume-title":"GenoType MTBDRplus VER 2.0: molecular genetic assay for identification of the M. tuberculosis complex and its resistance to rifampicin and isoniazid from clinical specimens and cultivated samples","author":"Hain Lifescience GmbH","year":"2015"},{"key":"e_1_2_13_31_2","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S222905"},{"key":"e_1_2_13_32_2","volume-title":"Line Probe Assays for Detection of Drug-Resistant Tuberculosis: Interpretation and Reporting Manual for Laboratory Staff and Clinicians","author":"WHO","year":"2022"},{"key":"e_1_2_13_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08709-z"},{"key":"e_1_2_13_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2014.09.007"},{"key":"e_1_2_13_35_2","article-title":"Characterization of Tuberculosis Among Newly Diagnosed Tuberculosis and Comorbid Tuberculosis-Diabetes Patients Residing in Nairobi and Kiambu Counties","volume":"115","author":"Mburu J. M.","year":"2020","journal-title":"Annals of the New York Academy of Sciences"}],"container-title":["Canadian Journal of Infectious Diseases and Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/cjid\/7830270","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1155\/cjid\/7830270","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/cjid\/7830270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T09:38:03Z","timestamp":1780133883000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/cjid\/7830270"}},"subtitle":[],"editor":[{"given":"Satabdi","family":"Datta Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1155\/cjid\/7830270"],"URL":"https:\/\/doi.org\/10.1155\/cjid\/7830270","archive":["Portico"],"relation":{},"ISSN":["1712-9532","1918-1493"],"issn-type":[{"value":"1712-9532","type":"print"},{"value":"1918-1493","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"2025-12-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"7830270"}}